The association between blood rheology and the ratio of low-density lipoprotein cholesterol (LDL-C) to high-density lipoprotein cholesterol (HDL-C) was investigated in 142 dyslipidaemic and 253 normolipidaemic subjects. Blood rheology was examined by the microchannel method and fasting serum concentrations of LDL-C, triglyceride and HDL-C were measured. Passage time of whole blood correlated positively with LDL-C concentration, triglyceride concentration and LDL-C/HDL-C ratio, and negatively with HDL-C concentration. Passage time of whole blood was significantly higher in dyslipidaemic and normolipidaemic subjects with LDL-C/HDL-C ratio > 2.0 than in those with ratio < 1.5. Thus, dyslipidaemic subjects had impaired blood rheology, elevated LDL-C and triglyceride concentrations and elevated LDL-C/HDL-C ratio, and reduced HDL-C concentrations. Dyslipidaemic and normolipidaemic subjects with a more elevated LDL-C/HDL-C ratio had greater blood rheology impairment than those with a less elevated ratio. These data suggest that an elevated LDL-C/HDL-C ratio may be helpful in predicting impaired blood rheology.
MartinMJHulleySBBrownerWS: Serum cholesterol, blood pressure, and mortality: Implications from a cohort of 361,662 men. Lancet1986; ii: 933–936.
2.
KannelWBCastelliWPGordonT: Serum cholesterol, lipoproteins, and the risk of coronary heart disease: The Framingham study. Ann Intern Med1971; 74: 1–12.
3.
KannelWB: Lipids, diabetes, and coronary heart disease: Insights from the Framingham Study. Am Heart J1985; 110: 1100–1107.
4.
ManninenVTenkanenLKoskinenP: Joint effects of serum triglyceride and LDL cholesterol and HDL cholesterol concentrations on coronary heart disease risk in the Helsinki Heart Study: Implications for treatment. Circulation1992; 85: 37–45.
5.
AssmannGSchulteH: Relation of high-density lipoprotein cholesterol and triglycerides to incidence of atherosclerotic coronary artery disease (the PROCAM experience). Am J Cardiol1992; 70: 733–737.
6.
NichollsSJTuzcuEMSipahiI: Statins, high-density lipoprotein cholesterol, and regression of coronary atherosclerosis. JAMA2007; 297: 499–508.
7.
ErnstEReschKL: Fibrinogen as a cardiovascular risk factor: A meta-analysis and review of the literature. Ann Intern Med1993; 118: 956–963.
8.
DaneshJCollinsRApplebyP: Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: Meta-analyses of prospective studies. JAMA1998; 279: 1477–1482.
9.
YarnellJWBakerIASweetnamPM: Fibrinogen, viscosity, and white blood cell count are major risk factors for ischemic heart disease. The Caerphilly and Speedwell collaborative heart disease studies. Circulation1991; 83: 836–844.
10.
KoenigWSundMFilipiakB: Plasma viscosity and the risk of coronary heart disease. Results from the MONICA–Augsburg Cohort Study, 1984 to 1992. Arterioscl Thromb Vasc Biol1998; 18: 768–772.
11.
LoweGDLeeAJRumleyA: Blood viscosity and risk of cardiovascular events: The Edinburgh Artery Study. Br J Haematol1997; 96: 168–173.
12.
LeeAJMowbrayPILoweGD: Blood viscosity and elevated carotid intima–media thickness in men and women. The Edinburgh Artery Study. Circulation1998; 97: 1467–1473.
13.
KoenigWSundMErnstE: Association between rheology and components of lipoproteins in human blood: Results from the MONICA Project Augsburg. Circulation1992; 85: 2197–2204.
14.
LeeCYJKimKCParkHW: Rheological properties of erythrocytes from male hypercholesterolemia. Microvasc Res2004; 67: 133–138.
15.
KuriharaTDeguchiSKatoJ: Impaired blood rheology by remnant-like lipoprotein particles: Studies in patients with fatty liver disease. Clin Hemorheol Microcirc2001; 24: 217–225.
16.
KikuchiYSatoKOhkiH: Optically accessible microchannels formed in a single-crystal silicon substrate for studies of blood rheology. Microvasc Res1992; 44: 226–240.
17.
SekiKSuminoHNaraM: Relationships between blood rheology and age, body mass index, blood cell count, fibrinogen, and lipids in healthy subjects. Clin Hemorheol Microcirc2006; 34: 401–410.
18.
SuminoHNaraMSekiK: Effect of antihypertensive therapy on blood rheology in patients with essential hypertension. J Int Med Res2005; 33: 170–177.
19.
SuminoHIchikawaSTakahashiT: Conjugated estrogen plus medroxyprogesterone does not impair blood rheological properties in hypertensive postmenopausal women. Maturitas2005; 53: 306–314.
20.
MuranakaYKunimotoFTakitaJ: Impaired blood rheology in critically ill patients in an intensive care unit. J Int Med Res2006; 34: 419–427.
21.
NaraMSuminoHNaraM: Impaired blood rheology and elevated remnant-like lipoprotein particle cholesterol in hypercholesterolaemic subjects. J Int Med Res2009; 37: 308–317.
22.
HataYMabuchiHSaitoY: Report of the Japan Atherosclerosis Society (JAS) Guideline for Diagnosis and Treatment of Hyperlipidemia in Japanese Adults. J Atheroscler Thromb2002; 9: 1–27.
23.
RosensonRSLoweGD: Effects of lipids and lipoproteins on thrombosis and rheology. Atherosclerosis1998; 140: 271–280.
24.
KanakarajiPSinghM: Influence of hypercholesterolemia on morphological and rheological characteristics of erythrocytes. Atherosclerosis1989; 76: 209–218.
25.
ChabanelAFlammMSungKL: Influence of cholesterol content on red cell membrane viscoelasticity and fluidity. Biophys J1983; 44: 171–176.
26.
EpandRMStaffordALeonB: HDL and apolipoprotein A-1 protect erythrocytes against the generation of procoagulant activity. Arterioscler Thromb1994; 14: 1775–1783.
27.
CichaISuzukiYTateishiN: Effects of dietary triglycerides on rheological properties of human red blood cells. Clin Hemorheol Microcirc2004; 30: 301–305.
28.
SeplowitzAHChienSSmithEF: Effects of lipoproteins on plasma viscosity. Atherosclerosis1981; 38: 88–95.
29.
RosensonRSShottSLuL: Hypertriglyceridemia and other factors associated with plasma viscosity. Am J Med2001; 110: 488–492.
30.
ContrerasTVayáAPalancaS: Influence of plasmatic lipids on the hemorheological profile in healthy adults. Clin Hemorheol Microcirc2004; 30: 423–425.
31.
ErcanMKoksalCKonukogluD: Impaired plasma viscosity via increased cholesterol levels in peripheral occlusive arterial disease [correction of disease]. Clin Hemorheol Microcirc2003; 29: 3–9.
BadimonJJBadimonLFusterV: Regression of atherosclerotic lesion by high density lipoprotein plasma fraction in the cholesterol-fed rabbit. J Clin Invest1990; 85: 1234–1241.
34.
ZilversmitDB: Atherogenic nature of triglycerides, postprandial lipemia, and triglyceride-rich remnant lipoproteins. Clin Chem1995; 41: 153–158.
35.
Ylae-HerttualaSPalinskyWRosenfeldME: Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man. J Clin Invest1989; 84: 1086–1095.
